[Use of cardiovascular agents in women during pregnancy].
Halawa
B
B
Katedry i Kliniki Kardiologii AM, Wrocławiu.
D000014:Abnormalities, Drug-Induced; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001942:Breast Feeding; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants
Stosowanie leków krazeniowych u kobiet w ciazy.